Evidence map›Paper›PMID 23118497›Full record

ArticleJournal of biomedicine & biotechnology2012

The serine protease plasmin triggers expression of the CC-chemokine ligand 20 in dendritic cells via Akt/NF-κB-dependent pathways.

Xuehua Li, Tatiana Syrovets, Thomas Simmet

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedicine & biotechnology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. CCL20 Expression via AKT-ERK1/2-AP1 Pathway inJournal of inflammation research · 2025
    Article
  3. An inhibitor of leukotriene-AProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
  5. Functions of the plasminogen receptor Plg-RJournal of thrombosis and haemostasis : JTH · 2020
    Review
  6. Article
  7. Article
  8. New insights into the role of Plg-RKT in macrophage recruitment.International review of cell and molecular biology · 2014
    Review
  9. Plasminogen receptors: the first quarter century.Seminars in thrombosis and hemostasis · 2013
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Xuehua LiInstitute of Pharmacology of Natural Products and Clinical Pharmacology, Universitat Ulm, Ulm, Germany.
Tatiana Syrovets
Thomas Simmet
Universität Ulm · DEHelmholtz-Institute Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of dendritic cells is increased in advanced atherosclerotic lesions. In addition, plasmin, which might stimulate dendritic cells, is generated in atherosclerotic lesions. Here, we investigated cytokine and chemokine induction by plasmin in human dendritic cells. In human atherosclerotic vessel sections, plasmin colocalized with dendritic cells and the CC-chemokine ligand 20 (CCL20, MIP-3α), which is important for homing of lymphocytes and dendritic cells to sites of inflammation. Stimulation of human dendritic cells with plasmin, but not with catalytically inactivated plasmin, induced transcriptional regulation of CCL20. By contrast, proinflammatory cytokines such as TNF-α, IL-1α, and IL-1β were not induced. The plasmin-mediated CCL20 expression was preceded by activation of Akt and MAP kinases followed by activation of the transcription factor NF-κB as shown by phosphorylation of its inhibitor IκBα, by nuclear localization of p65, its phosphorylation, and binding to NF-κB consensus sequences. The plasmin-induced CCL20 expression was dependent on Akt- and ERK1/2-mediated phosphorylation of IκBα on Ser32/36 and of p65 on Ser276, whereas p38 MAPK appeared to be dispensable. Thus, plasmin triggers release of the chemokine CCL20 from dendritic cells, which might facilitate accumulation of CCR6(+) immune cells in areas of plasmin generation such as inflamed tissues including atherosclerotic lesions.

Indexed as

AtherosclerosisChemokine CCL20Dendritic CellsEnzyme ActivationExtracellular Signal-Regulated MAP KinasesFibrinolysinGene Expression RegulationHumansNF-kappa Bp38 Mitogen-Activated Protein KinasesProtein TransportProto-Oncogene Proteins c-aktRNA, MessengerSignal TransductionTime FactorsCCL20 protein, humanChemokine CCL20Extracellular Signal-Regulated MAP KinasesFibrinolysinNF-kappa Bp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktRNA, Messenger

Identifiers

PMID23118497
PMCPMC3480669
OpenAlexW2111067579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.